morphiceptin has been researched along with 16,16-dimethylprostaglandin f2alpha in 1 studies
| Studies (morphiceptin) | Trials (morphiceptin) | Recent Studies (post-2010) (morphiceptin) | Studies (16,16-dimethylprostaglandin f2alpha) | Trials (16,16-dimethylprostaglandin f2alpha) | Recent Studies (post-2010) (16,16-dimethylprostaglandin f2alpha) |
|---|---|---|---|---|---|
| 139 | 0 | 12 | 11 | 1 | 0 |
| Protein | Taxonomy | morphiceptin (IC50) | 16,16-dimethylprostaglandin f2alpha (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.016 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.016 | |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dervarics, M; Fülöp, F; Martinek, TA; Otvös, F; Tóth, G | 1 |
1 other study(ies) available for morphiceptin and 16,16-dimethylprostaglandin f2alpha
| Article | Year |
|---|---|
Ligand-based prediction of active conformation by 3D-QSAR flexibility descriptors and their application in 3+3D-QSAR models.
Topics: Amino Acids; Drug Design; Ligands; Models, Molecular; Molecular Conformation; Oligopeptides; Quantitative Structure-Activity Relationship; Statistics as Topic; Stereoisomerism; Thermodynamics | 2005 |